Julianne Hibbs DO

Dr. Lorraine Dougherty, a board-certified oncologist based in Chalfont, PA, specializes in hematology and medical oncology, offering individualized treatment plans tailored to each patient's needs. With extensive experience in cancer diagnosis and treatment, she is dedicated to preserving her patients' quality of life and has been recognized in Philadelphia Magazine's Top Doc List for 2020 and 2021. Affiliated with several hospitals, including Grand View Hospital and Doylestown Hospital, Dr. Dougherty collaborates closely with her colleagues to explore innovative treatment options, including clinical trials. Her commitment to patient care is exemplified through the supportive environment she fosters, ensuring that patients receive comprehensive guidance and compassionate support throughout their treatment journey. Generated from the website

James L. Spears, MD, is a board-certified oncologist and hematologist at Alliance Cancer Specialists in Chalfont, PA, specializing in comprehensive cancer care that prioritizes the individual needs of patients. With extensive experience in diagnosing and treating various types of cancer, Dr. Spears is dedicated to providing compassionate and thorough care, ensuring that patients feel supported throughout their treatment journey. As an active member of the American Society of Clinical Oncology and the American Medical Association, Dr. Spears has been recognized by his peers in Philadelphia Magazine's Top Doc List for 2020 and 2021. The practice emphasizes collaboration and communication, with a focus on exploring innovative treatment options, including clinical trials, to enhance patient outcomes and quality of life. Generated from the website

Dr. Sarah Goodyear, M.D., completed her fellowship in Hematology and Oncology at Fox Chase Cancer Center. Dr. Goodyear received her medical degree from the Temple University School of Medicine, where she also completed her Internal Medicine internship and residency. Dr. Goodyear is a current member of the American Society of Clinical Oncology.